Daewi Kim
YOU?
Author Swipe
View article: Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products — United States, October 2024–February 2025
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products — United States, October 2024–February 2025 Open
Maternal respiratory syncytial virus (RSV) vaccine and nirsevimab, a long-acting monoclonal antibody for infants aged 0-7 months and children aged 8-19 months who are at increased risk for severe RSV disease, became widely available for pr…
View article: P-1188. Mortality among U.S. Children Aged < 18 Years Hospitalized with Laboratory-confirmed Respiratory Syncytial Virus (RSV) Infection, 12 States, 2018–2019, 2021–2022, 2022–2023
P-1188. Mortality among U.S. Children Aged < 18 Years Hospitalized with Laboratory-confirmed Respiratory Syncytial Virus (RSV) Infection, 12 States, 2018–2019, 2021–2022, 2022–2023 Open
Background Pediatric RSV-associated hospitalizations are well-described but mortality data are limited. Methods RSV Hospitalization Surveillance Network (RSV-NET), a 12-state population-based surveillance system, captured laboratory-confir…
View article: COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024
COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 Open
Among adults, COVID-19 hospitalization rates increase with age. Data from the COVID-19-Associated Hospitalization Surveillance Network were analyzed to estimate population-based COVID-19-associated hospitalization rates during October 2023…
View article: 1105. Clinical outcomes in non-pregnant adults aged ≥18 years hospitalized with laboratory-confirmed RSV infection, 12 U.S. states, October 2014–April 2022
1105. Clinical outcomes in non-pregnant adults aged ≥18 years hospitalized with laboratory-confirmed RSV infection, 12 U.S. states, October 2014–April 2022 Open
Background Respiratory syncytial virus (RSV) is an important cause of respiratory illness and hospitalization in older adults and adults with certain underlying medical conditions. With novel RSV vaccines in development, it is critical to …
View article: 2296. Trends in reasons for hospital admission among adults ≥18 years hospitalized with laboratory-confirmed SARS-CoV-2 infection—COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), 14 U.S. States, June 2020 – January 2023
2296. Trends in reasons for hospital admission among adults ≥18 years hospitalized with laboratory-confirmed SARS-CoV-2 infection—COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), 14 U.S. States, June 2020 – January 2023 Open
Background During the COVID-19 pandemic, hospitals performed widespread screening for SARS-CoV-2, resulting in identification of asymptomatic or mildly ill persons with SARS-CoV-2 who were admitted for other reasons. We examined trends in …
View article: 412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020
412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020 Open
Background Since the start of the Coronavirus Disease 2019 (COVID-19) pandemic, comparisons between hospitalized COVID-19 and influenza patients diagnosed with pneumonia are scarce. The objective of this study was to compare characteristic…
View article: Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023 Open
View article: Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023 Open
Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in older adults. In May 2023, two RSV vaccines were approved for prevention of RSV lower respiratory tract disease in adults aged ≥60 years. In June 2023, CDC rec…
View article: Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021
Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021 Open
Most COVID-19-associated hospitalizations occur in older adults, but severe disease that requires hospitalization occurs in all age groups, including adolescents aged 12-17 years (1). On May 10, 2021, the Food and Drug Administration expan…